Monthly Prescribing Reference
   
Subscribe to our RSS feeds RSS | Login | Register
  • HOME
  • SPECIALTY
    • Hematology-Oncology
    • Long Term Care
    • Nurse Practitioners
    • OB/GYN
    • Pharmacists
    • Physician Assistants
    • Primary Care Physicians
    • Residents
    • Urologists
  • THERAPEUTIC CATEGORIES
  • BRAND
  • GENERIC
  • COMPARE
  • NEWS
    • Drug News
    • Drugs in the Pipeline
    • Drug Safety Alerts and Recalls
    • New Drug Products
    • Polls & Surveys
    • Newsletters
    • News from Haymarket Journals
  • RESOURCES
    • Alerts (Sponsored)
    • Clinical Charts
    • Common Medical Abbreviations
    • Company
    • Drug Monograph Format
    • FDA Orange Book
    • Pharmacology Notes
    • Professional Associations
    • Video
    • Blogs
    • MPR Publications
    • Customer Service
    • Online Banner Ad Specs
    • Subscribe
  • DOWNLOAD
  • CME
  • JOBS
  • #
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
Home > Manufacturers > T > Takeda Pharmaceuticals America, Inc.

Takeda Pharmaceuticals America, Inc.

 

Address:

475 Half Day Road
Lincolnshire, IL 60069

Email:

NA

Website:

click to visit

Phone:

(877) 825-3327

Fax:

NA

 
Compare | Add to Clipboard | View Clipboard
Name Section Compare
ACTOPLUS MET 15mg/500mg
Endocrine System > Diabetes
compare
ACTOPLUS MET 15mg/850mg
Endocrine System > Diabetes
compare
ACTOS
Endocrine System > Diabetes
compare
DUETACT 30mg/2mg
Endocrine System > Diabetes
compare
DUETACT 30mg/4mg
Endocrine System > Diabetes
compare
KAPIDEX
Gastrointestinal Tract > Hyperacidity, GERD, and ulcers
compare
PREVACID
Gastrointestinal Tract > Hyperacidity, GERD, and ulcers
compare
PREVACID for ORAL SUSP
Gastrointestinal Tract > Hyperacidity, GERD, and ulcers
compare
PREVACID NAPRAPAC 375
Musculoskeletal Disorders > Arthritis/rheumatic disorders
compare
PREVACID NAPRAPAC 500
Musculoskeletal Disorders > Arthritis/rheumatic disorders
compare
PREVACID SOLUTAB
Gastrointestinal Tract > Hyperacidity, GERD, and ulcers
compare
PREVPAC
Gastrointestinal Tract > Hyperacidity, GERD, and ulcers
compare
ROZEREM
Central Nervous System > Insomnia
compare
ULORIC
Musculoskeletal Disorders > Gout
compare
  • Most Popular
  • Most Emailed
  • Most Recent
  • FDA reviews atypical subtrochanteric femur fractures risk with oral bisphosphonates
  • Kapidex to be marketed under new trade name Dexilant
  • Hizentra approved for primary immunodeficiency
  • Xiaflex available for Dupuytren's contracture
  • Trelstar 22.5mg approved for palliative treatment of prostate cancer
  • Pediaderm HC Complete Kit available for atopic dermatitis
  • New Product: SAPHRIS® (asenapine) Sublingual Tablets
  • Botox approved for upper limb spasticity
  • FDA halts marketing of unapproved nitroglycerin tablets
  • FDA accepts NDA for lurasidone, a treatment for schizophrenia
  • FDA reviews atypical subtrochanteric femur fractures risk with oral bisphosphonates
  • Recommended Adult Immunization Schedule
  • Prevnar 13 pneumococcal disease vaccine approved
  • Xiaflex available for Dupuytren's contracture
  • Hizentra approved for primary immunodeficiency
  • Kapidex to be marketed under new trade name Dexilant
  • Ampyra available for multiple sclerosis patients
  • FDA grants priority review to Tasigna for newly diagnosed chronic myeloid leukemia
  • FDA accepts NDA for JZP-6, a treatment for fibromyalgia
  • Rituxan approved for chronic lymphocytic leukemia
  • FDA halts marketing of unapproved nitroglycerin tablets
  • Hibiclens General Skin Cleansing Patient Kit available
  • Bowel Cleansers
  • Neosalus Cream available for dermatitis
  • FDA warns of reduced Plavix efficacy in poor metabolizers
  • Five-day dosing regimen for Dacogen approved for myelodysplastic syndromes (MDS)
  • FDA reviews atypical subtrochanteric femur fractures risk with oral bisphosphonates
  • Trelstar 22.5mg approved for palliative treatment of prostate cancer
  • FDA accepts NDA for lurasidone, a treatment for schizophrenia
  • FDA warns of intravascular hemolysis risk with WinRho SDF
Sponsored Links

MPR SITEMAP


Search our Drug Database

Browse by Brand
Browse by Generic
Browse by Manufacturer
Browse by Therapeutic Category

News

News
Drug News
New Drug Products
Polls & Surveys
Newsletters

Clinical Charts

Clinical Charts

Resources

Resources
Pharmacology Notes
Alerts (Sponsored)

Therapeutic Categories

Allergic Disorders
Cardiovascular System
Central Nervous System
Dental
Dermatological Disorders
Diagnostic Agents
Ear Disorders
Endocrine System
Eye Disorders
Gastrointestinal Tract
Hematology
Immune System
Infections & Infestations
Musculoskeletal Disorders
Neoplasms
Nutrition
OB/GYN
Pain & Pyrexia
Poisoning & Drug Dependence
Respiratory Tract
Urogenital System

More

Customer Service
Subscribe
Advertise
About Us
Permissions
MPR Publications
Disclaimer
Subscribe to our RSS feeds RSS


Other Haymarket Medical Websites


Cortlandt Forum

Clinical Advisor

Renal and Urology News

JAAPA

myCME - Online CME

McKnights Long Term Care News

International

healthcare republic

MIMS (drug database)
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions